Financhill
Back

Protagonist Therapeutics Vs. SoftBank Group Industry Stock Comparison

Sell
48

PTGX
Protagonist Therapeutics

Last Price:
44.34
Seasonality Move:
13.52%
Sell
45

SFTBY
SoftBank Group

Last Price:
29.86
Seasonality Move:
1.61%
Sell
48
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $44.37. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
SoftBank Group (SFTBY) is a Sell

Is SoftBank Group a Buy, Sell or Hold?

  • The current SoftBank Group [SFTBY] share price is $29.86. The Score for SFTBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • SFTBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $44.37
    The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.

SFTBY Stock Price Chart

What is SoftBank Group's stock price today?

  • The SoftBank Group share price today is $29.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 51.2 Buy
Chaikin Money Flow: -191605 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.06 - 46.3) Sell
Bollinger Bands (100): (32.41 - 43.17) Buy

SFTBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 53.06 Buy
Chaikin Money Flow: 400281 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.84 - 30.42) Buy
Bollinger Bands (100): (27.1 - 32.74) Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.83 Sell
20-day SMA: 45.37 Sell
50-day SMA: 42.21 Buy
200-day SMA: 32.24 Buy
8-day EMA: 44.81 Sell
20-day EMA: 44.61 Sell
50-day EMA: 42.28 Buy
200-day EMA: 33.58 Buy

SFTBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.89 Sell
20-day SMA: 29.58 Buy
50-day SMA: 28.51 Buy
200-day SMA: 27.85 Buy
8-day EMA: 29.75 Buy
20-day EMA: 29.52 Buy
50-day EMA: 29.38 Buy
200-day EMA: 27.81 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.

SoftBank Group Earnings Growth & SFTBY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

SoftBank Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):